SCN1A mutations are the main cause of the epilepsy disorders Dravet syndrome (DS) and genetic epilepsy with febrile seizures plus (GEFS+). Mutations that reduce the activity of the mouse Scn8a gene, in contrast, are found to confer seizure resistance and extend the lifespan of mouse models of DS and GEFS+. To investigate the mechanism by which reduced Scn8a expression confers seizure resistance, we induced interictal-like burst discharges in hippocampal slices of heterozygous Scn8a null mice (Scn8a med/+ ) with elevated extracellular potassium.
SCN1A mutations are the main cause of the epilepsy disorders Dravet syndrome (DS) and genetic epilepsy with febrile seizures plus (GEFS+) . Mutations that reduce the activity of the mouse Scn8a gene, in contrast, are found to confer seizure resistance and extend the lifespan of mouse models of DS and GEFS+. To investigate the mechanism by which reduced Scn8a expression confers seizure resistance, we induced interictal-like burst discharges in hippocampal slices of heterozygous Scn8a null mice (Scn8a med/+ ) with elevated extracellular potassium.
Scn8a
med/+ mutants exhibited reduced epileptiform burst discharge activity after P20, indicating an agedependent increased threshold for induction of epileptiform discharges. Scn8a deficiency also reduced the occurrence of burst discharges in a GEFS+ mouse model (Scn1a R1648H/+ ). There was no detectable change in the expression levels of Scn1a (Na v 1.1) or Scn2a (Na v 1.2) in the hippocampus of adult Scn8a med/+ mutants. To determine whether the increased seizure resistance associated with reduced Scn8a expression was due to alterations that occurred during development, we examined the effect of deleting Scn8a in adult mice. Global Cre-mediated deletion of a heterozygous floxed Scn8a allele in adult mice was found to increase thresholds to chemically and electrically induced seizures. Finally, knockdown of Scn8a gene expression in the adult hippocampus via lentiviral Cre injection resulted in a reduction in the number of EEG-confirmed seizures following the administration of picrotoxin. Our results identify the hippocampus as an important structure in the mediation of Scn8a-dependent seizure protection and suggest that selective targeting of Scn8a activity might be efficacious in patients with epilepsy. © 2014 Elsevier Inc. All rights reserved.
Introduction
Epilepsy is characterized by unprovoked, recurrent seizures that are manifestations of abnormal neuronal synchrony and excitability. Several genes that are known to cause monogenic forms of epilepsy encode neuronal ion channels, including voltage-gated sodium channels (VGSCs) (Noebels, 2003; Steinlein, 2004) . VGSCs are important integrators of synaptic input and are responsible for the initiation and propagation of action potentials in neurons (Gong et al., 1999; Lorincz and Nusser, 2010; Whitaker et al., 2001) . Three pore-forming VGSC α-subunit genes are primarily expressed in the adult mammalian central nervous system (CNS): SCN1A, SCN2A, and SCN8A, which encode the Na v 1.1, Na v 1.2, and Na v 1.6 channels, respectively. SCN1A has emerged as an important epilepsy gene and is responsible for a number of different epilepsy disorders, including the catastrophic, treatmentresistant childhood encephalopathy Dravet syndrome (DS) and genetic epilepsy with febrile seizures plus (GEFS+) (Claes et al., 2001; Escayg et al., 2000) .
Approximately 30% of epileptic patients do not achieve adequate seizure control with currently available anti-epilepsy drugs (AEDs). Moreover, while new AEDs are generally better tolerated, the percentage of patients with treatment-resistant seizures has not changed significantly in the last 40 years, indicating a critical need to identify new treatment options for patients with refractory epilepsy. VGSCs are known targets for several AEDs; however, these drugs are not isoform specific and affect all VGSCs, likely contributing to unwanted side effects. Alternatively, selective targeting of a specific VGSC isoform, may provide improved seizure control with fewer unintended consequences.
We previously demonstrated that thresholds for flurothyland kainic acid-induced seizures are elevated in Scn8a med/+ and Scn8a medjo/+ mutant mice when compared to wild-type (WT) littermates (Martin et al., 2007) . Furthermore, the seizure phenotypes of Scn1a mutant mice that model DS and GEFS+ were dramatically improved by the co-expression of an Scn8a mutation (Hawkins et al.,
